Lantern Pharma Inc. (LTRN)
NASDAQ · Manufacturing · Pharmaceutical preparations
$1.22+$0.0100 (+0.83%) on the dayAs of the close; data may be delayed.
LTRN price, last 12 months
Key stats
- Previous close
- $1.21
- Open
- $1.17
- Day range
- $1.15 – $1.28
- 52-week range
- $1.11 – $4.70
- Volume
- 211.3K
- Avg volume (20 days)
- 236.7K
- Market cap
- $15.6M
Performance
1W−21.3%
1M−44.0%
3M−68.4%
6M−41.6%
YTD−59.7%
1Y−73.4%
vs S&P 500, 1Y−90.1 pts
Technicals and fundamentals
About Lantern Pharma Inc.
Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $15.6M